View in EDS

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.

Saved in:
Bibliographic Details
Title: Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
Authors: Espeseth AS; Merck & Co., Inc., Rahway, New Jersey, USA., Yuan M; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Citron M; Merck & Co., Inc., Rahway, New Jersey, USA., Reiserova L; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Morrow G; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Wilson A; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Horton M; Merck & Co., Inc., Rahway, New Jersey, USA., Rukhman M; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Kinek K; Merck & Co., Inc., Rahway, New Jersey, USA., Hou F; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Li SL; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Li F; Merck & Co., Inc., Rahway, New Jersey, USA., Choi Y; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Heidecker G; Merck & Co., Inc., Rahway, New Jersey, USA., Luo B; Merck & Co., Inc., Rahway, New Jersey, USA., Wu G; Merck & Co., Inc., Rahway, New Jersey, USA., Zhang L; Merck & Co., Inc., Rahway, New Jersey, USA., Strable E; Merck & Co., Inc., Rahway, New Jersey, USA., DeStefano J; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Secore S; Merck & Co., Inc., Rahway, New Jersey, USA., Mukhopadhyay TK; Merck & Co., Inc., Rahway, New Jersey, USA., Richardson DD; Merck & Co., Inc., Rahway, New Jersey, USA., Sayeed E; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA., Welch LS; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA; Currently at Clover Biopharmaceuticals, Boston, Massachusetts, USA., Bett AJ; Merck & Co., Inc., Rahway, New Jersey, USA., Feinberg MB; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA., Gupta SB; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA., Cooper CL; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA., Parks CL; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA. Electronic address: cparks@iavi.org.
Source: EBioMedicine [EBioMedicine] 2022 Aug; Vol. 82, pp. 104203. Date of Electronic Publication: 2022 Jul 30.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35915046
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Espeseth+AS%22">Espeseth AS</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+M%22">Yuan M</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Citron+M%22">Citron M</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Reiserova+L%22">Reiserova L</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Morrow+G%22">Morrow G</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Horton+M%22">Horton M</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Rukhman+M%22">Rukhman M</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kinek+K%22">Kinek K</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Hou+F%22">Hou F</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Li+SL%22">Li SL</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Li+F%22">Li F</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Heidecker+G%22">Heidecker G</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Luo+B%22">Luo B</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Wu+G%22">Wu G</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Strable+E%22">Strable E</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22DeStefano+J%22">DeStefano J</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Secore+S%22">Secore S</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Mukhopadhyay+TK%22">Mukhopadhyay TK</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+DD%22">Richardson DD</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Sayeed+E%22">Sayeed E</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.<br /><searchLink fieldCode="AU" term="%22Welch+LS%22">Welch LS</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA; Currently at Clover Biopharmaceuticals, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bett+AJ%22">Bett AJ</searchLink>; Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Feinberg+MB%22">Feinberg MB</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+SB%22">Gupta SB</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), New York, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+CL%22">Cooper CL</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA.<br /><searchLink fieldCode="AU" term="%22Parks+CL%22">Parks CL</searchLink>; The International AIDS Vaccine Initiative, Inc. (IAVI), Vaccine Design and Development Laboratory, New York, USA. Electronic address: cparks@iavi.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101647039%22">EBioMedicine</searchLink> [EBioMedicine] 2022 Aug; Vol. 82, pp. 104203. <i>Date of Electronic Publication: </i>2022 Jul 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101647039 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523964%22">23523964 </searchLink><i>NLM ISO Abbreviation: </i>EBioMedicine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35915046
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ebiom.2022.104203
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104203
    Titles:
      – TitleFull: Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Espeseth AS
      – PersonEntity:
          Name:
            NameFull: Yuan M
      – PersonEntity:
          Name:
            NameFull: Citron M
      – PersonEntity:
          Name:
            NameFull: Reiserova L
      – PersonEntity:
          Name:
            NameFull: Morrow G
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Horton M
      – PersonEntity:
          Name:
            NameFull: Rukhman M
      – PersonEntity:
          Name:
            NameFull: Kinek K
      – PersonEntity:
          Name:
            NameFull: Hou F
      – PersonEntity:
          Name:
            NameFull: Li SL
      – PersonEntity:
          Name:
            NameFull: Li F
      – PersonEntity:
          Name:
            NameFull: Choi Y
      – PersonEntity:
          Name:
            NameFull: Heidecker G
      – PersonEntity:
          Name:
            NameFull: Luo B
      – PersonEntity:
          Name:
            NameFull: Wu G
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Strable E
      – PersonEntity:
          Name:
            NameFull: DeStefano J
      – PersonEntity:
          Name:
            NameFull: Secore S
      – PersonEntity:
          Name:
            NameFull: Mukhopadhyay TK
      – PersonEntity:
          Name:
            NameFull: Richardson DD
      – PersonEntity:
          Name:
            NameFull: Sayeed E
      – PersonEntity:
          Name:
            NameFull: Welch LS
      – PersonEntity:
          Name:
            NameFull: Bett AJ
      – PersonEntity:
          Name:
            NameFull: Feinberg MB
      – PersonEntity:
          Name:
            NameFull: Gupta SB
      – PersonEntity:
          Name:
            NameFull: Cooper CL
      – PersonEntity:
          Name:
            NameFull: Parks CL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3964
          Numbering:
            – Type: volume
              Value: 82
          Titles:
            – TitleFull: EBioMedicine
              Type: main
ResultId 1